Operations

Program Medical Director

The Program Medical Director (“PMD”), Hope to Health Research and Innovation Complex (H2H), is responsible, in partnership with the Clinical Operations Director, for the planning and implementation of existing clinical services. These include longitudinal and episodic primary care, provision of opioid agonist therapy (OAT), provision of injectable OAT, harm reduction services, safer drug supply, supervised consumption site, clinical teaching and specialist care. The program medical director will also be responsible for the development of future clinical services at H2H.

Program Medical Director Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below